Document:

AGREEMENT

This Agreement is made effective as of August 10, 2006 by and between China
Biopharmaceuticals Holdings Inc. (the "Company") with its principal business
office located in China, and Zixun Capital Limited ("Zixun") residing at British
Virgin Island.

WHEREAS, Zixun has identified Enshi International Holdings ("Enshi" and such
acquisition shall be referred to below as the "Enshi Acquisition") as the
acquisition target for the Company and assisted the Company in its acquisition
of Enshi;

WHEREAS, Zixun has provided a third party performance guarantee of up to
US$1,000,000 for the completion of the Company's acquisition of Enshi to the
shareholders of Enshi to ensure that Enshi enter into the merger agreement and
suspend other merger negotiations ; NOW THEREFORE, in consideration for the
mutual covenants and agreements hereinafter set forth, the parties hereby agree
as follows:

1. SERVICES. During the term of this Agreement, Zixun shall have advised the
Company on the acquisition by the Company of 100% of the issued and outstanding
share capital of Enshi and further acquisitions of the other acquisition
targets. Zixun shall provide cash deposits up to $1 million USD (up to one year)
for securing the execution of the Enshi Acquisition whenever the
shareholder/shareholders of Enshi require it.

2. COMPENSATION. Compensation is success-based. If the Company successfully
completes Enshi Acquisition at the purchasing price of lower than $ 15,000,000
USD, The Company shall issue Zixun or any person or institution designated by
Zixun, 1,100,000 shares of common stock of the Company, within two month after
the closing of Enshi Acquisition.

3. EXPENSE REIMBURSEMENT. Zixun is compensated on a success basis and shall not
be entitled to reimbursing from the Company for any "out-of-pocket" expenses.

4. TERMINATION. This Agreement shall be effective until December 31, 2006.

5. RELATIONSHIP OF PARTIES. It is understood by the parties that Zixun is an
independent contractor with respect to the Company, and not an employee of the
Company. The Company will not provide fringe benefits, including health issuance
benefits, paid vacation, or any other employee benefit, for the benefit of
Zixun.

6. ASSIGNMENT. Zixun's obligations and the Services under this Agreement may not
be assigned or transferred to any other person, firm, or corporation without the
prior written consent of Company, which consent may be withheld in the absolute
discretion of the Company, it being understood that the Company has engaged
Zixun because of its special and unique knowledge and business experience.

7. CONFIDENTIALITY. In view of the fact that Zixun's work for the Company will
bring Zixun into close contact with confidential affairs, information and plans
for future developments of the Company not readily available to the public, as
well as access to certain trade secrets pertaining to the business of the
Company, all of which Zixun acknowledges are proprietary to and the exclusive
property of the Company, Zixun agrees:
<PAGE>

a. to keep and retain in the strictest confidence, except that which is
available in the public domain, all confidential matters of the Company,
including, without limitation, inventions, products, prices, apparatus, business
affairs, technical information, customer lists, product design information,
trademarks, copyrights, and other proprietary information (collectively,
"Information") which are valuable, special and unique assets of Company and need
to be protected from improper disclosure. In consideration for the disclosure of
the Information, Zixun agrees that Zixun will not at any time or in any manner,
either directly or indirectly, use any Information for Zixun's own benefit, or
divulge, disclose, or communicate in any manner any Information to any third
party without the prior written consent of the Company. Zixun will protect the
Information and treat it as strictly confidential.

b. to deliver promptly to the Company on termination of Zixun's engagement, or
at any time the Company may so request, all memoranda, notes, records, reports,
manuals, drawings, blueprints and other documents and all copies thereof,
including computer programs, discs, software, etc., relating to the Company's
business, operations, financial condition, Intellectual Property and all other
tangible and intangible property associated therewith which Zixun may possess or
have under Zixun's control.

8. UNAUTHORIZED DISCLOSURE OF INFORMATION. If it appears that Zixun has
disclosed (or has threatened to disclose) Information in violation of this
Agreement, the Company shall be entitled to an injunction to restrain Zixun from
disclosing, in whole or in part, such Information, or from providing any
services to any party to whom such Information has been disclosed or may be
disclosed. The Company shall not be prohibited by this provision from pursuing
other remedies, including a claim for losses and damages.

9. CONFIDENTIALITY AND NONSOLICITATION AFTER TERMINATION. The confidentiality
provisions of this Agreement shall remain in full force and effect for three (3)
years following the termination of this Agreement. Zixun agrees so long as
Company is in compliance with its obligations under this Agreement that during
the Term and for one (1) year after the termination, it will not, directly or
indirectly, without the prior written consent of the Company, induce or solicit
any person employed or hereafter employed by the Company to leave the employ of
the Company or solicit, recruit, hire or attempt to solicit, recruit or hire any
person employed by the Company. Further, Zixun agrees that for a period of one
(1) year after the termination of this Agreement, it will not, directly or
indirectly, without the prior written consent of the Company, solicit for any
business similar to that of the Company, divert away, take away, or attempt to
take away any customer of the Company who was a customer or a potential customer
at the time of termination or expiration of this Agreement. Further, Zixun and
Company agree that neither will disparage, defame, slander, libel or otherwise
speak negatively of the other or of any affiliate, officer, director or employee
of the other.

10. RETURN OF RECORDS. Upon termination of this Agreement, Zixun shall deliver
all records, notes, data, memoranda, models, and equipment of any nature that
are in Zixun's possession or under Zixun's control and that are the Company's
property or relate to the Company's business.
<PAGE>

11. INDEMNIFICATION

a. Zixun shall indemnify and hold the Company harmless from and against any and
all liabilities, damages, claims, costs and expenses, including, without
limitation, reasonable fees and disbursements of counsel, arising in connection
with, or incident to any breach or violation by Zixun of any covenant or
agreement contained in this Agreement or otherwise arising out of any of the
transactions contemplated by this Agreement and with any claims, liabilities or
damages resulting from claims against the Company.

b. The Company shall indemnify and hold Zixun harmless from and against any and
all liabilities, damages, claims, costs and expenses, including, without
limitation, reasonable fees and disbursements of counsel, arising in connection
with, or incident to any breach or violation of any covenant or agreement
contained in this Agreement or otherwise arising out of any of the transactions
contemplated by this Agreement.

12. AMENDMENT. This Agreement may be modified or amended if the amendment is
made in writing and is signed by both parties.

13. SEVERABILITY. If any provision of this Agreement shall be held to be invalid
or unenforceable for any reason, the remaining provisions shall continue to be
valid and enforceable. If a court finds that any provision of this Agreement is
invalid or unenforceable, but that by limiting such provision it would become
valid and enforceable, then such provision shall be deemed to be written,
construed, and enforced as so limited.

14. WAIVER OF CONTRACTUAL RIGHT. The failure of either party to enforce any
provision of this Agreement shall not be construed as a waiver or limitation of
that party's right to subsequently enforce and compel strict compliance with
every provision of this Agreement.

15. APPLICABLE LAW AND DISPUTE RESOLUTION.

15.1 Applicable Law

The execution, validity, construing and performance of this Agreement, and
resolution of the disputes under this Agreement, shall be in accordance with the
laws of the State of New York, the United States of America..

15.2 Dispute Resolution

The Parties shall make good faith effort to settle any dispute arising from the
interpretation or performance of this Agreement through friendly negotiation. In
case no settlement can be reached, each Party shall submit the dispute to an
arbitration panel ("Panel") under the auspices of the American Arbitration
Association ("AAA") at a venue located in New York City. The Panel shall consist
of one or three to be selected by the mutual agreement of the Parties. If the
Parties can not agree on the arbitrator, each may select one arbitrator and the
two designated arbitrators shall select the third arbitrator. If the third
arbitrator can not be agreed upon, the American Arbitration Association in New
York shall select the third arbitrator. A majority decision by the three
arbitrators shall be final and binding upon and enforceable against the Parties.
Such arbitration shall follow the rules of the AAA.
<PAGE>

15.3 Enforceability

Arbitration shall be the only remedy for the Parties in any dispute. There
Parties hereby waive any right to litigate any dispute, including but not
limited to the exclusivity of this arbitration provision contained in Section 12
in any court. The Parties hereby submit themselves to the exclusive
jurisdiction.

16. ENTIRE AGREEMENT. This Agreement together contains the entire understandings
and agreements of the parties, and there are no other promises or conditions or
understandings in any other agreement, whether oral or written. This Agreement
supersedes any prior written or oral understandings or agreements between the
parties.

In Witness Whereof, the parties have executed this Agreement as of the date
first above written.

China Biopharmaceuticals Holdings, Inc.

By: /s/ Chris Peng Mao
    ---------------------------------
    Chris Peng Mao
    Chief Executive Officer

Zixun Capital Limited

By: /s/ SIU LAI CHAU
    ---------------------------------
    SIU LAI CHAU
    DirectorExhibit
      10.1

     

    SOLOMON
      TECHNOLOGIES, INC.

    SENIOR
      SECURED PROMISSORY NOTE

    

    

    THIS
      NOTE
      HAS NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS
      AMENDED, OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD OR OTHERWISE
      TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR
      AN
      OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE ISSUER THAT SUCH REGISTRATION
      IS NOT REQUIRED UNDER SUCH ACT AND LAWS.

     

    
      	
              $200,000.00
                

            	
              May
                23, 2006

            

    

     

    FOR
      VALUE
      RECEIVED, SOLOMON TECHNOLOGIES, INC., a Delaware corporation (“Company”), with
      its principal office at 1400 L&R Industrial Boulevard, Tarpon Springs,
      Florida 34689, hereby promises to pay to the order of Coady Family LLC
      (“Holder”), with a principal address at 1320 Pony Farm Road, Jacksonville, North
      Carolina 28540 (the “Holder’s Address”), or its assigns, on June 30, 2006 (the
“Maturity Date”), the principal amount of TWO HUNDRED THOUSAND DOLLARS
      ($200,000.00) (the “Principal Amount”), in such coin or currency of the United
      States of America as at the time of payment shall be legal tender for the
      payment of public or private debts, together with interest on the unpaid balance
      of said Principal Amount from time to time outstanding at the rate of twelve
      percent (12%) per annum (“Interest”). The unpaid Principal Amount, together with
      the then accrued unpaid Interest and all other amounts owed hereunder, shall
      be
      due and payable on the Maturity Date. Payment of the Principal Amount and
      Interest hereunder shall be made by check to the Holder at the Holder’s Address
      or wire transfer of immediately available good funds to such bank account as
      the
      Holder may designate by notice to the Company prior to any such
      payment.

    

    This
      Note
      is one of a series of substantially similar notes of the Company with an
      aggregate principal amount of up to $1,600,000 (collectively, the “Notes”). The
      Notes shall be payable pari passu
      with
      each other but shall at all times be senior to any other indebtedness of the
      Company in right of payment of principal, interest and all other sums due or
      payable, and all other present and future indebtedness and obligations of the
      Company, other than accrued taxes or taxes due and payable. 

     

    The
      Company has executed a security agreement dated as of March 16, 2005 (as
      amended, restated or modified from time to time, the “Security Agreement”),
      pursuant to which the Holder and the holders of the other Notes have been
      granted a first priority security interest in the “Collateral” identified
      therein.

     

    This
      Note
      is subject to prepayment in whole or in part at any time and from time to time
      without penalty or premium, but with Interest on the amount prepaid to the
      date
      of prepayment. All prepayments will first be applied to the repayment of accrued
      fees and expenses, then to Interest accrued on this Note through the date of
      such prepayment until all then outstanding accrued Interest has been paid,
      and
      then shall be applied to the repayment of the Principal Amount.

    
      
        
        

      

      
        
        

        
          

        

      

       

    

    

    1. Default.

    

    1.1 Events
      of Default.
      Upon
      the occurrence of any of the following events (herein “Events of
      Default”):

    

    (i) The
      Company shall fail to pay the Principal Amount and Interest on this or any
      other
      Note on the Maturity Date;

    

    (ii) (A) The
      Company shall commence any proceeding or other action relating to it in
      bankruptcy or seek reorganization, arrangement, readjustment of its debts,
      receivership, dissolution, liquidation, winding-up, composition or any other
      relief under any bankruptcy law, or under any other insolvency, reorganization,
      liquidation, dissolution, arrangement, composition, readjustment of debt or
      any
      other similar act or law, of any jurisdiction, domestic or foreign, now or
      hereafter existing; or (B) the
      Company shall admit the material allegations of any petition or pleading in
      connection with any such proceeding; or (C) the
      Company shall apply for, or consent or acquiesce to, the appointment of a
      receiver, conservator, trustee or similar officer for it or for all or a
      substantial part of its property or admit generally an inability to pay its
      debts as they become due; or (D) the
      Company shall make a general assignment for the benefit of
      creditors;

    

    (iii) (A) The
      commencement of any proceedings or the taking of any other action against the
      Company in bankruptcy or seeking reorganization, arrangement, readjustment
      of
      its debts, liquidation, dissolution, arrangement, composition, or any other
      relief under any bankruptcy law or any other similar act or law of any
      jurisdiction, domestic or foreign, now or hereafter existing and the continuance
      of any of such event for thirty (30) days undismissed, unbonded or undischarged;
      or (B) the
      appointment of a receiver, conservator, trustee or similar officer for the
      Company for any of its property and the continuance of any of such event for
      thirty (30) days undismissed, unbonded or undischarged; or (C) the
      issuance of a warrant of attachment, execution or similar process against any
      of
      the property of the Company and the continuance of such event for thirty (30)
      days undismissed, unbonded and undischarged;

    

    (iv) Any
      of
      the Company’s representations or warranties contained herein is determined by a
      court of competent jurisdiction as false or misleading in any material respect;
      or

    

    (v) The
      Company shall breach or fail to perform or observe any obligation, covenant,
      term, condition, provision or agreement of the Company contained in this Note
      or
      in any of the other Notes, after giving effect to any applicable notice
      provisions and cure periods; provided, however, that with respect to a failure
      to comply with any of the provisions of Sections 2.2(a) and (c) of this Note,
      such failure is not remedied within twenty (20) days after the Company’s receipt
      of written notice of same; 

     

    then,
      and
      in any such event, the Holder, at its option and without written notice to
      the
      Company, may declare the entire Principal Amount of this Note then outstanding
      together with any accrued Interest thereon immediately due and payable, and
      the
      same shall forthwith become immediately due and payable without presentment,
      demand, protest, or other notice of any kind, all of which are expressly waived,
      and exercise any and all other legal or equitable rights resulting therefrom.
      Upon the occurrence of an Event of Default that remains uncured as set forth
      herein and the placement of this Note in the hands of an attorney for
      collection, the Company agrees to pay reasonable collection costs and expenses,
      including reasonable attorneys’ fees and interest from the date of the Event of
      Default at the rate of eighteen percent (18%) per annum computed on the unpaid
      principal balance. The Events of Default listed herein are solely for the
      purpose of protecting the interests of the Holder of this Note.

    
      
        
        

      

      
        2

        
          

        

      

       

    

     

    1.2 Non-Waiver
      and Other Remedies.
      No
      course of dealing, delay or omission on the part of the Holder of this Note
      in
      exercising any right hereunder shall operate as a waiver or otherwise prejudice
      the right of the Holder of this Note. Holder shall not be deemed to have waived
      any of its rights under this Note unless such waiver is in writing and signed
      by
      Holder. A waiver in writing by Holder on one occasion shall not be construed
      as
      a consent to or a waiver of any right or remedy on any future occasion. No
      remedy conferred hereby shall be exclusive of any other remedy referred to
      herein or now or hereafter available at law, in equity, by statute or
      otherwise.

    

    2.
      Obligation
      to Pay Principal and Interest; Covenants.
      No
      provision of this Note shall alter or impair the obligation of the Company,
      which is absolute and unconditional, to pay the Principal Amount of and Interest
      on this Note at the place, at the respective times, at the rates, and in the
      currency or securities herein prescribed.

    

    2.1 In
      no
      event shall the amount or rate of interest due and payable under this Note
      exceed the maximum amount or rate of interest allowed by applicable law and,
      in
      the event any such excess payment is made by Company or received by Holder,
      such
      excess sum shall be credited as a payment of Principal Amount (or if no
      Principal Amount remains outstanding, shall be refunded to the Company). It
      is
      the express intent hereof that the Company shall not pay and Holder not receive,
      directly or indirectly or in any other manner, interest in excess of that which
      may be lawfully paid under applicable law. All Interest (including all charges,
      fees or other amounts deemed to be Interest) that is paid or charged under
      this
      Note shall, to the maximum extent permitted by applicable law, be amortized,
      allocated and spread on a pro rata
      basis
      throughout the actual term of this Note.

    

    2.2 Covenants.
      The
      Company covenants and agrees that, while this Note is outstanding, it
      shall:

    

    (a) Pay
      and
      discharge all taxes, assessments and governmental charges or levies imposed
      upon
      it or upon its income and profits, or upon any properties belonging to it before
      the same shall be in default; provided, however, that the Company shall not
      be
      required to pay any such tax, assessment, charge or levy that is being contested
      in good faith by proper proceedings and adequate reserves for the accrual of
      same are maintained if required by generally accepted accounting principles;
      

    

    (b) Preserve
      its corporate existence and continue to engage in business of the same general
      type as conducted as of the date hereof;

    

    (c) Comply
      in
      all respects with all statutes, laws, ordinances, orders, judgments, decrees,
      injunctions, rules, regulations, permits, licenses, authorizations and
      requirements (“Requirement(s)”) of all governmental bodies, departments,
      commissions, boards, companies or associations insuring the premises, courts,
      authorities, officials, or officers, that are applicable to the Company; except
      when the failure to comply would not have a material adverse effect on the
      Company; provided that nothing contained herein shall prevent the Company from
      contesting in good faith the validity or the application of any
      Requirements.

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    

    3. Miscellaneous.

    

    3.1 Required
      Consent.
      The
      Company may not modify any of the terms of this Note without the prior written
      consent of the Holder.

    

    3.2 Lost
      Documents.
      Upon
      receipt by the Company of evidence satisfactory to it of the loss, theft,
      destruction or mutilation of this Note or any Note exchanged for it, and (in
      the
      case of loss, theft or destruction) of indemnity satisfactory to it, and upon
      surrender and cancellation of such Note, if mutilated, the Company will make
      and
      deliver in lieu of such Note a new Note of like tenor and unpaid principal
      amount and dated as of the original date of the Note.

    

    3.3  Legend.
      This
      Note shall be imprinted with a legend in substantially the following
      form:

    

    THIS
      NOTE
      HAS NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS
      AMENDED, OR ANY OTHER STATE SECURITIES LAWS AND MAY NOT BE SOLD OR OTHERWISE
      TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR
      AN
      OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE ISSUER THAT SUCH REGISTRATION
      IS NOT REQUIRED UNDER SUCH ACT AND LAWS. 

    

    3.4 Benefit.
      This
      Note shall be binding upon and inure to the benefit of the parties hereto and
      their legal representatives, successors and assigns.

    

    3.5 Notices
      and Addresses.
      All
      notices, offers, acceptances and any other acts under this Note (except payment)
      shall be in writing, and shall be sufficiently given if delivered to the
      addressee in person, by overnight courier service or similar receipted delivery,
      or, if mailed, postage prepaid, by certified mail, return receipt requested,
      as
      follows:

    
      	 	
               

              To
                the Holder:

            	
               

              To
                the Holder’s address on page 1 of this Note,

              Attn.:
                Patrick Coady, Manager

               

            
	 	
              To
                the Company:

               

            	
              To
                the Company’s address on page 1 of this Note,

              Attn:
                Peter W. DeVecchis, Jr., President

               

            
	 	
              With
                a copy to:

            	
              Davis
                & Gilbert LLP

              1740
                Broadway

              New
                York, New York 10019

              Attn: Ralph
                W. Norton, Esq.

            

    

    

    or
      to
      such other address as any party, by notice to the other parties, may designate
      from time to time. Time shall be counted to, or from, as the case may be, the
      delivery in person or five business days after mailing. 

    
      
        
        

      

      
        4

        
          

        

      

       

    

    

    3.6 Governing
      Law.
      This
      Note will be deemed to have been made and delivered in New York and will be
      governed as to validity, interpretation, construction, effect and in all other
      respects by the internal laws of the State of New York. 

     

    3.7 Section
      Headings.
      Section
      headings herein have been inserted for reference only and shall not be deemed
      to
      limit or otherwise affect, in any matter, or be deemed to interpret in whole
      or
      in part any of the terms or provisions of this Note.

    

    3.8 Interpretation.
      Whenever possible, each provision of this Note shall be interpreted in such
      manner as to be effective and valid under applicable law, but if any provision
      of this Note shall be prohibited by or invalid under applicable law, such
      provision shall be ineffective only to the extent of such prohibition or
      invalidity, without invalidating the remainder of such provision or the
      remaining provisions of this Note.

    

      
      3.9 Assignment.
      All
      rights of Holder under this Note may be assigned by Holder to any third party
      and all rights of Holder hereunder shall inure to the benefit of its
      transferees, successors and assigns.

     

    IN
      WITNESS WHEREOF, this Note has been executed and delivered on the date specified
      above by the duly authorized representatives of the Company and the
      Holder.

     

    
      	 	 	 
	 	SOLOMON
              TECHNOLOGIES, INC.
	 
 	 
 	 
 
	
            	By:  	/s/
              Peter W. DeVecchis, Jr.
	 	
              
                

              

              Name: Peter
                W. DeVecchis, Jr. 

              Title: President 

            

    
      	 	 	 
	 	COADY
              FAMILY LLC
	 
 	 
 	 
 
	
            	By:  	/s/
              Patrick Coady  
	 	
              
                

              

              Name:
                Patrick Coady

              Title:
                Manager

            

    

    
      
        
        

      

      
        5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}]]